GlaxoSmithKline to shut down Shanghai R&D lab

By Nell Walker
Despite a former status as a hub of scientific innovation, GlaxoSmithKline is set to close its Shanghai R&D centre. The lab had been leading GSK...

Despite a former status as a hub of scientific innovation, GlaxoSmithKline is set to close its Shanghai R&D centre.

The lab had been leading GSK’s research in neurological diseases like Alzheimer’s, Parkinson’s and multiple sclerosis. The company has stated:

“Following a portfolio review and prioritisation, we have decided to close our neuroscience R&D centre in Shanghai and move key programs to our global R&D hub in Upper Providence in the US, where they will benefit from colocation with other pipeline R&D programs.”

This news comes just a couple of weeks after the announcement that the business is selling its rare diseases business as part of its £1bn cost-cutting drive.

GSK began investing in China ten years ago, and had high hopes from the beginning that it would be a shining jewel of the business. A global leader in multiple sclerosis research, Jingwu Zang, led the centre but was fired in 2013 before a wider controversy hit. Eventually, 110 staff in China were fired due to ethical violations, and GSK was forced to pay $500mn to the Chinese government.

This series of events has led to this Shanghai closure, GlaxoSmithKline has said that despite the closure of this particular lab, business in China will continue:

“The China R&D development organization will continue to be based in Shanghai and is set to expand over the next two years to accelerate the development of new medicines,” the firm said. “We remain committed to China and will focus our R&D efforts in China on the needs of China, at both our Shanghai site and our Institute for Infectious Diseases & Public Health in Beijing.”

Share

Featured Articles

What to see and do at GSMA MWC Shanghai 2024

At the 2024 GSMA MWC in Shanghai, guests will learn more about the future of 5G and IoT, as well as the role of mobile connectivity in manufacturing

EV Recycling Driven By Tata Steel, Nucor and Dowa Holdings

Market projected growth for EV recycling set to go from US$551bn in 2024 to US$768bn by 2029 with Tata Steel and Nucor embracing ferrous metal recycling

Brooke Weddle: Manufacturing Needs A Rebrand

Brooke Weddle, senior partner at Mckinsey, sat down with Manufacturing Digital to discuss methods to address manufacturing's global hiring crisis

Immensa and Intaj Suhar partner to boost Omani manufacturing

Procurement & Supply Chain

Bain & Company Report: OEMs and Digital Transformation

Smart Manufacturing

The Factory of the Future: Manufacturers' Biggest Challenges

Smart Manufacturing